Soleus Capital, based in Greenwich, manages hedge fund and private equity strategies focused on the healthcare sector. The firm aims for risk-adjusted returns over time through a long/short equity strategy, primarily investing in publicly traded healthcare companies in the U.S. and internationally.
Guy Levy, founder and Managing Partner of Soleus Capital Management brings over 18 years of financial services experience and deep expertise in various healthcare sub-verticals. Under his leadership, Soleus has been a lead investor in healthcare companies such as Galecto, Antios Therapeutics, and Beta Bionics. Before founding Soleus Capital, Guy worked as a partner, portfolio manager, and investment analyst at Paulson & Co., Shumway Capital, Warburg Pincus, and Morgan Stanley. He holds a B.A. from Yale University.
As of March 2024, Soleus Capital Management manages discretionary assets totaling $1.98 billion across eight clients. Their Q1 2024 13F filing reported $1.35 billion in managed 13F securities with a top 10 holdings concentration of 44.95%. The firm's largest holding is the SPDR Biotech ETF, with 2.2 million shares.
| Fund Name: | Soleus Capital |
| Manager | Guy Levy |
| Portfolio Value | $1,291,482,757 |
| Change This QTR | +1.14% |
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | Spdr Series TrustCALLCALL | 900,000 | $88,920,000 | NEW | 6.88% | ||
| 2. | IOVA | 8,528,500 | $80,082,615 | +13% | 6.2% | ||
| 3. | TGTX | 2,534,540 | $59,282,891 | -31% | 4.59% | ||
| 4. | TERN | 6,223,544 | $51,904,357 | +26% | 4.01% | ||
| 5. | AXGN | 3,005,943 | $42,143,321 | -10% | 3.26% |
